Liver failure/CABG/ESRD Flashcards
MELD score
used to prioritize organ allocation to adult pts
NBC-I
Na, bili, Cr, INR
platypnea
dyspnea worsening in the upright position
hepatopulmonary syndrome
liver disease
decrease oxygenation (PaO2 < 70)
intrapulm vascular dilation (pulm angio, perfusion lung scan)
dyspnea in End stage liver disease
heptopulm syndrome
pleural edema
alcoholic cardiomyopathy
cirrhotic cardiomyopathy
2/2 smoking or COPD
or a combo
perks of paracentesis preop
-inc cardiac output (relieves compression on IVC)
-improved pulm gas exchange (inc pulm compliance, dec V/Q mismatch)
-dec risk of aspration (stomach compression)
**ensure adequate volume expansion w/ colloids
Diagnosis of hepatorenal syndrome
- presence of advc liver dx and portal HTN
- lower GFR Cr > 1.5 or GFR < 40
- absence of shock, infxn, fluid loss, or nephrotoxic agents
- no sustained improvement in renal function w/ administration of fluids/albumin
- no proteinuria, urinary obstruction or parenchymal renal dx
pathophysiology of hepatorenal syndrome
portal HTN -> relase of vasodilators substances (nitric oxidee) -> splanchnic arterial vasodilation -> activation of the renin-angiotensin-aldo system -> inc absorption of water and Na and kidney vasoconstriction -> contuined decreased perfusion to kidneys
Type I: rapidly progressive w/i 2 weeks
type II: slower onset
Meds to help w/ hepatorenal syndrome while waiting for transplant
albumin (volume expander)
midodrine (vasoconstrictor)
octreotide (inhbits splanchnic vasodilation)
moderate pulm HTN
35-45
pulm HTN
> 25
pulm pressure CI to liver transplant
> 50
Concerns w/ hepatic encephalopathy and anesthesia
-hypoK: can inc production of ammonia, make it worse
-maintain normal pH -> alkalemia can inc diffusion of ammonia across BBB
-correct hypovolemia or anemia: optimize liver metabolism of circulating toxicns
-careful w/ benosz: suppresion of CNS can exacerbate his condition
pathophysiology of hepatopulmonary syndrome
portal hypertension -> hyperdynamic circulation and fluid overload -> splanchnic volume overload and bowel edema -> bacterial translocation and cytokine activation -> inc activation of macrophages in lungs -> inc/accumulation of nitric oxide to promote vasodiatlion w/ accumulation of MP -> abnormal pulmonary dilation and blunting of HPV
Goals for coags preop in end stage liver dx
plts > 50-60,000
INR < 1.5
no signs of active bleeding
veno-veno bypass in liver transplant
femoral and portal veins are cannulated to reroute blood flow from below the diaphragm to the suprahepatic vena cava (axillary, subclavian or jugular vein)
-minimizes interruption of caval flow from anhepatic phase
-adv: improved cardiac filling, dec blood and fluid requirements, improved surgical field
-disadv: inc risk of air embolism, thromboembolism, arm lymphedema, hematoma, vascular/n inury